新聞Novo Nordisk A/S acquired TiGenix on Oct 1st '21.Novo Nordisk and TiGenix: In October 2021, Novo Nordisk announced its acquisition of TiGenix, a regenerative medicine company focused on developing stem cell therapies.
新聞Takeda in Belgium acquires TiGenix for $1B.Prior to this, Dr. Leselbaum was Director Clinical Development at Tigenix, which was acquired by Takeda for more than half a billion euros.
新聞Takeda acquires TiGenix for $559M.Already on the first day of the J.P. Morgan Conference, Celgene announced its staged $7B acquisition of Impact Biomedicines while Takeda announced its agreement to acquire TiGenix for €520MM.
